Jim Buck Recognized as Finalist for EY US Entrepreneur of the Year 2025 in Mid-Atlantic Region

Jim Buck Recognized as EY US Entrepreneur of the Year 2025 Finalist

In a significant recognition for innovation and leadership, Jim Buck, the President and CEO of Medcura, Inc., has been named a finalist for the EY US Entrepreneur of the Year 2025 Mid-Atlantic Award. This prestigious accolade celebrates exceptional entrepreneurs who drive meaningful change and have a lasting impact on their communities and industries.

The EY Entrepreneur Of The Year program, which marks its 40th anniversary this year, aims to honor bold leaders who are reshaping the business landscape. It recognizes entrepreneurs whose groundbreaking enterprises and creative solutions disrupt traditional markets and pave the way for a more vibrant economy.

An independent panel of judges selected Buck as a finalist due to his entrepreneurial spirit and transformational approaches that have led to significant advancements in medical technology. Under his leadership, Medcura has pioneered the development of multiple state-of-the-art medical devices, ranging from implantable cardioverter defibrillators to portable MRI systems. With a focus on innovation, he has directed the company towards creating cutting-edge hemostasis solutions designed to enhance surgical outcomes.

One of Medcura's flagship products, LifeGel™, stands out as the first and only absorbable hemostatic gel that enjoys the FDA's Breakthrough Device Designation. This remarkable product is specially designed to control surgical bleeding during spine surgeries, offering improved safety and effectiveness. Buck commented, “LifeGel is just the beginning. The technology behind LifeGel has the potential to expand across various surgical applications, and we are exploring new product formats, such as films, powders, and textiles.”

The Entrepreneur Of The Year program highlights leaders who have displayed ingenuity and courage in their business journeys. It honors those who reinvent their companies and those who leverage external funding to expand their organizations significantly. The upcoming regional award ceremony, scheduled for June 18 in Washington, DC, will recognize winners who then enter a distinguished community of past awardees from around the globe.

Furthermore, following the regional announcements, the winners are also eligible for the National Entrepreneur Of The Year Awards, which take place in November during the Strategic Growth Forum® – a premier event showcasing high-growth companies across the nation.

Medcura continues to grow as a crucial player in the medical sector, with ongoing developments in their product line that emphasize innovative, effective, and cost-efficient solutions for bleeding control during surgical procedures. As a commercial-stage medical device company, they are committed to delivering products that not only meet current medical needs but also anticipate future requirements in healthcare.

For more details on Jim Buck and Medcura’s groundbreaking innovations and offerings, visit www.medcurainc.com. As we celebrate Buck’s achievements, it’s clear that his contributions to technology and healthcare will continue to shape the landscape for years to come.